Gemfibrozil Cost-Benefit Study
- 1 January 1990
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 40 (Supplement) , 42-52
- https://doi.org/10.2165/00003495-199000401-00010
Abstract
This cost-benefit analysis attempts to translate the clinical findings of the Helsinki Heart Study (HHS) and published results regarding additional cardiovascular conditions into economic terms...Keywords
This publication has 3 references indexed in Scilit:
- A Randomized Controlled Trial of Hospital Discharge Three Days after Myocardial Infarction in the Era of ReperfusionNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.American Journal of Public Health, 1987